Brainreader develops advanced healthcare-grade AI based decision support software. Our technology analyzes medical imaging to provide one of the most comprehensive solutions for flagging acute abnormalities across the brain, helping healthcare professionals prioritize life threatening cases and expedite patient care.
Facts about Brainreader:
- Founded in 2011
- CE marked in 2013
- FDA cleared in 2015
- HIPAA compliant
- Cover all states in the US with Sales and Support
Brainreader was founded in 2011 with the creation of Neuroreader®. The groundbreaking idea was to develop a medical software that can detect abnormal brain patterns from MRI brain scans in a nuanced and personalized way.
The award-winning Neuroreader® is now a sought after assessment tool that increases the speed and accuracy for quantifying brain structures as compared to the gold standard of manual segmentation. Neuroreader® assists physicians in discovering neurodegenerative diseases and is used for monitoring the progression of diagnosed brain disorders.
Early diagnosis of neurodegenerative conditions can result in treatment plans that improve quality of life, prolong the disease progressions, and help patients and family members effectively cope with a neurodegenerative disease. With its automated algorithms, Neuroreader® can assist with early diagnosis by producing a brain volumetric data report in less than 10 minutes.
Today, Brainreader is one of the leading global players within the field of brain volumetrics.